Abstract The Global Meningococcal Initiative (GMI) was established in 2009 and comprises
an international team of scientists, clinicians, and public health officials with expertise in …

Outbreaks of invasive meningococcal disease (IMD) are unpredictable, can be sudden and
have devastating consequences. We conducted a non-systematic review of the literature in …

During 2010, outbreaks of serogroup C meningococcal (MenC) disease occurred in 2 oil
refineries in São Paulo State, Brazil, leading to mass vaccination of employees at 1 refinery …

Background Routine infant immunization with meningococcal C conjugate (MCC)
vaccination started in Brazil in November 2010, scheduled at three and five months plus a …

Phenotypic and genotypic characterization of 133 isolates of Neisseria meningitidis
obtained from meningococcal disease cases in Argentina during 2010 were performed by …

Background: In 2010, introduction of the meningococcal C conjugate vaccine in Brazil for
children< 2 years provided an immediate reduction in the incidence rates of disease among …

Background Meningococcal disease is caused by the bacteria Neisseria meningitidis,
leading to substantial mortality and severe morbidity; with serogroups A, B, C, W135, X and …

To prevent secondary invasive meningococcal disease (IMD) cases and outbreaks,
antimicrobial prophylaxis of high-risk contacts is indicated. This study reports two …

Abstract Background Mass gatherings (MGs) such as the Hajj and Umrah pilgrimages are
known to amplify the risk of invasive meningococcal disease (IMD) due to enhanced …

Background With the upcoming licensure of Outer Membrane Protein-based vaccines
against meningococcal disease, data on disease incidence and molecular characteristic of …